Confusion and dysphoria with low-dose topiramate in a patient with bipolar disorder

Bipolar Disorders

Volumn 3, Issue 4, 2001, Pages 211-212

  Andrade, Chittaranjan ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Adverse effects; Bipolar disorder; Confusion; Dysphoria; Topiramate

Indexed keywords

ANTICONVULSIVE AGENT; CLONAZEPAM; LITHIUM; PSYCHOTROPIC AGENT; RISPERIDONE; TOPIRAMATE; VALPROIC ACID;

ADULT; AKATHISIA; ANAMNESIS; ARTICLE; ASIAN; CASE REPORT; CLINICAL FEATURE; CONFUSION; CONTROLLED STUDY; DOSE RESPONSE; DYSPHORIA; HUMAN; MALE; MANIC DEPRESSIVE PSYCHOSIS; MENTAL DISEASE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; SYMPTOM; THOUGHT DISORDER;

EID: 0034848515     PISSN: 13985647     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-5618.2001.30406.x     Document Type: Article

References (12)

1. Topiramate as add-on treatment for patients with bipolar mania
2. Treatment of acute mania with topiramate
3. Open-label adjunctive topiramate in the treatment of bipolar disorders
4. A double-blind, randomized, placebo-controlled, parallel study to determine the efficacy of topiramate in the prophylactic treatment of migraine
5. Efficacy of topiramate in migraine prophylaxis: A retrospective chart analysis
6. Efficacy and safety of topiramate in the treatment of painful diabetic neuropathy: A double-blind, placebo-controlled study
7. Mood stabilization and weight loss with topiramate
8. Clozapine weight gain, plus topiramate weight loss
9. Topiramate
10. Effects of topiramate on cognitive function
11. A double-blind, placebo-controlled study of topiramate in adult patients with refractory partial epilepsy
12. A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures